The type I IFN-a/b gene family was identified about a quarter of a century ago as a prototype of many cytokine gene families, which led to the subsequent burst of studies on molecular mechanisms underlying cytokine gene expression and signaling. Although originally discovered for their activity to confer an antiviral state on cells, more evidence has recently been emerging regarding IFN-a/b actions on cell growth, differentiation and many immunoregulatory activities, which are of even greater fundamental biological significance. Indeed, much attention has recently been focused on the induction and function of the IFN-a/b system regulated by Toll-like receptors (TLRs), which are critical for linking the innate and adaptive immunities. The understanding of the regulatory mechanisms of IFN-a/b gene induction by TLRs and viruses is an emerging theme, for which much new insight has been gained over the past few years.
Introduction
IFN-a and -b were originally identified as humoral factors that confer an antiviral state on cells, and these cytokines constitute a family, termed type I IFNs, which encompasses a group of structurally related genes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . In humans and mice, multiple functional IFN-a gene subtypes exist, whereas a single gene exists for IFN-b (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . The pleiotropic roles of IFN-a/b in various biological systems have been uncovered further in recent studies.
Most notably, the IFN-a/b system gained much attention in the context of Toll-like receptor (TLR) signaling that modulates the development of innate and adaptive immune systems (12) (13) (14) (15) (16) . In brief, the stimulation of antigen-presenting cells (APCs) by pathogen-associated molecules, such as LPS, unmethylated DNA (CpG DNA) and double-stranded RNA (dsRNA), via distinct TLR family members leads to the expression of various effector molecules, including IFN-a/b (15) (16) (17) (18) (19) (20) . IFN-a/b then contribute to the induction of the expression of co-stimulatory molecules, such as CD40 and CD86, and the functional maturation of APCs (12, 21, 22) . Recombinant IFN-a/b potently enhance the antibody response (including the induction of isotype switching) through the stimulation of dendritic cells (DCs) (23) . Furthermore, the cross-presentation of antigens on MHC class I molecules, the induction of CTL responses and the subsequent memory CD8 + T cell survival are also dependent on IFN-a/b (24) (25) (26) (27) (28) . In addition to immune modulation, IFN-a/b affect cellular development and homeostasis. In the bone marrow, type I IFNs are weakly produced and regulate the homeostatic differentiation of hematopoietic cells, such as B cells, T cells, osteoclasts and myeloid DCs (29) (30) (31) (32) (33) . Although the underlying mechanisms are still unknown, in most cases, IFN signaling negatively affects hematopoietic cell development. Evidence has also been provided that IFN-a/b contribute to anti-tumor activities and the control of cell growth (34, 35) . These findings underscore the broad biological activities of type I IFNs in maintaining the normal immune homeostasis as well as in preserving the integrity of many cell types.
The induction of IFN-a/b is regulated primarily at the transcriptional level, wherein IFN regulatory factors (IRFs) play central roles (36) (37) (38) . Our knowledge concerning the mechanism underlying the transcriptional regulation of IFN-a/b genes has rapidly expanded over the past few years, particularly in the context of TLR signaling. The mechanism by which pathogen-derived ligands and respective host receptors, including TLRs, trigger the IFN-a/b induction is becoming clearer. Furthermore, the availability of newly generated mice deficient in one or two transcription factors of the IRF family has allowed us to obtain clearer pictures of the contribution of each IRF member to the transcriptional regulation of these genes. In this review, we focus on recent studies on the transcriptional regulation of IFN-a/b genes and its immunological significance.
IFN-a/b signaling and induction of target genes; an overview
The IFN-a/b signaling pathway and the activation of the target genes have been reviewed in depth elsewhere (3-11, 29, 39, 40) , and only a brief description on the cardinal features will be made below. All IFN-a/b species interact with the same receptor complex, termed the IFN-a/b receptor (IFNAR), which consists of at least two subunits, IFNAR1 and IFNAR2. The intracellular domains of IFNAR1 and IFNAR2 are associated with the Janus family of protein tyrosine kinases (Jak kinases), Tyk2 and Jak1, respectively. The binding of IFNa/b to IFNAR results in the cross-activation of these Jak kinases, which then phosphorylate IFNAR1, Stat1 and Stat2. These Stats recruited to the phosporylated IFNAR1 form two distinct transcriptional activator complexes, namely, IFN-aactivated factor (AAF) and IFN-stimulated gene factor 3 (ISGF3). AAF is a homodimer of Stat1, whereas ISGF3 is a heterotrimeric complex of Stat1, Stat2 and IRF-9 (also known as p48 or ISGF3c). AAF and ISGF3 translocate into the nucleus, and bind to specific DNA sequences, named the IFNc-activated sequence (GAS) and the IFN-stimulated response element (ISRE), respectively. IFN-signaling results in the transcriptional induction of hundreds of target genes (IFNstimulated genes), which include the genes for dsRNAactivated serine/threonine protein kinase, 29,59-oligoadenylate synthetase and the p53 tumor suppressor (5) (6) (7) (8) (9) (10) (11) 34) . Other target genes critical for the induction of IFN-a/b genes include IRF-7, TLR3, TLR7 and the dsRNA-recognition molecule retinoic acid-inducible gene I (RIG-I) (41) (42) (43) (44) .
IFN-a/b gene enhancers and IRFs
The promoter region of the IFN-b gene contains at least four regulatory cis-elements: the positive regulatory domains (PRDs) I, II, III and IV (45) (46) (47) (Fig. 1) . The PRD I and PRD III elements are activated by members of the IRF family (36-38, 46, 48-55) . On the other hand, PRD II and PRD IV elements, as yet not identified in the IFN-a promoters, are activated by nuclear factor jB (NF-jB) and ATF-2/c-Jun, respectively (47, 48, (56) (57) (58) (59) (60) . As for the promoter region of IFN-a genes, PRD I-and III-like elements (PRD-LEs) that bind IRFs have been identified (61) (62) (63) (64) , but it still remains elusive whether or not other transcription factors contribute to the induction of these genes.
The prototype IRF family molecule IRF-1 was first discovered as a transcriptional activator that binds to PRD I or III of the human IFNB1 gene (50) . Subsequently, other IRFs have been discovered and the mammalian IRF family now comprises nine members (36) (37) (38) . It has been demonstrated that many of these IRF family members play a pivotal role in diverse biological processes, including immunity, inflammation and apoptosis (36) (37) (38) 65) . All these members are characterized by the presence of a well-conserved N-terminal DNA-binding domain of about 120 amino acids, which recognizes similar DNA sequences (consensus; 59-GAAANNGAAAG/CT/C-39), termed ISRE, which is similar to the PRD and PRD-LEs found in the IFN-a/b promoters (39, 66) .
Among IRFs, at least four members, namely, IRF-1, IRF-3, IRF-5 and IRF-7, have been implicated as the regulators of IFN-a/b gene transcription (36-38, 50, 67) . Although IRF-1 is the first discovered IRF member in the context of IFN gene induction (50) , the induction of both IFN-a and IFN-b mRNAs by Newcastle disease virus (NDV) remains essentially normal in Irf1-deficient embryonic fibroblasts (MEFs) (68) . In addition, it has also been demonstrated that the dsRNA-or virusmediated IFN induction in MEFs derived from Irf5-deficient mice is normal (69) , indicating that neither IRF-1 nor IRF-5 is essential for gene induction. As will be described below, it appears that IRF-7 is the master regulator of IFN-a/b gene induction, whereas IRF-3 also critically participates depending on the nature of the stimuli (70, 71) . It must be mentioned, however, that IRF-1 may be involved in the induction of IFN-a and -b genes by dsRNA in fibroblasts (68) and by CpG DNA in some DCs (K.H., unpublished results).
IFN induction pathway in virus-infected fibroblasts: the classical pathway
IRF-3-mediated IFN gene induction (early view)
In the 1990s, the studies of the transcriptional regulation of IFNs were mainly carried out using virus-infected fibroblasts. In this context, the role of IRF-3 has been extensively studied among IRF family members. IRF-3 is expressed constitutively in a variety of cells and localizes in the cytoplasm as an inactive monomer (54, (72) (73) (74) (75) (76) (77) . IRF-3 has potential virusmediated phosphorylation sites in the C-terminal region (Ser385, 386, 396, 398, 402 and 405, and Thr404 of human IRF-3). Phosphorylation of Ser396 was first reported by using phospho-specific antibody (78) . Another report demonstrated that phosphorylation of Ser386 is the critical determinant for the activation of IRF-3 (79) . No direct evidence of phosphorylation for the remaining five serine/threonine sites has been reported. The phosphorylation event induces IRF-3 activation and homodimerization (54, (72) (73) (74) (75) (76) (77) (78) (79) . Based on the crystal structure of IRF-3, there are two models of IRF-3 activation and dimerization. One is 'the phosphorylation-induced dimerization model', in which phosphorylation at Ser385 or Ser386 of IRF-3 induces dimerization (80) . The other model is 'the autoinhibitory model', in which two regions corresponding to residues 380-427 and 98-240 of IRF-3 mutually interact to form a closed structure in the inhibited state. This structure is opened by the introduction of massive negative charges following the multiple phosphorylation of C-terminal serine/ threonine residues, resulting in IRF-3 activation and dimerization (81) . Whatever the mechanism, the dimeric form of IRF-3 then translocates to the nucleus, forms a complex with coactivator p300/CBP and binds to the PRD I or PRD III element (54, (72) (73) (74) (75) (76) (77) (78) (79) . The active IRF-3 is also known to directly induce chemokine genes such as RANTES and IP10 during viral infection (82) (83) (84) .
In the early view, IRF-3 was thought to be primarily 
IRF-7-mediated IFN gene induction in fibroblasts (current view)
IRF-7 was first described to bind and repress the Qp promoter region of the EBV-encoded gene EBNA-1, which contains an ISRE-like element (87) . Similar to IRF-3, IRF-7 mainly resides in the cytoplasm and requires the phosphorylation of C-terminal serine residues for its activation and nuclear translocation (41, 42, 88, 89) . The Ser437 and 438 residues of murine IRF-7 are the primary targets of phosphorylation, but an additional phosphorylation of the Ser425-426, Ser429-431 or Ser441 residue is required to fully activate IRF-7 in virus-infected cells (90) . It has been shown that, similar to IRF-3, IRF-7 also undergoes dimerization to activate its target genes (41, 42, 88, 89). As described above, the expression of the IRF-7 gene is regulated by IFN-a/b-activated ISGF3 (41, 42) . In addition, it has been shown that IRF-3 is potent in activating the IFN-b gene rather than most of the IFN-a genes (except for the IFN-a4 gene), whereas the ectopic expression of IRF-7 causes the activation of both IFN-a and IFN-b genes (41, 42, 71, 83) . Therefore, it was considered that IRF-7 is involved in the late phase of IFN-a/b gene induction, contributing to the positivefeedback regulation for the robust IFN-a/b production in antiviral immunity.
Only very recently, Irf7-deficient mice (Irf7 ÿ/ÿ mice) have been generated, allowing the rigorous assessment of the above view of the positive-feedback regulation (70) . In MEFs from 
IRF kinases
Recently, TANK-binding kinase 1 (TBK1; also known as T2K and NAK) and inducible IjB kinase (IKKi; also known as IKKe) have been identified as virus-activated IRF-3 and IRF-7 kinases (91, 92) . Indeed, in MEFs derived from Tbk1-deficient mice, IFN-a/b mRNA induction was shown to be diminished in response to VSV or Sendai virus infection (93) (94) (95) ). An in vitro study suggests that cyclophilin B (CypB), a member of the immunophilin family of cis-trans peptidyl-prolyl isomerases, is also involved in virus-mediated IRF-3 phosphorylation (96) . Although the exact function of CypB has remained unclarified, considering the fact that CypB has an endoplasmic reticulum (ER)-directed signal sequence (97), ER might be involved in the IFN induction pathway. As a key upstream regulator of the virus-mediated IRF-3 or IRF-7 activation, RIG-I was recently identified (44) . RIG-I mediates the recognition of dsRNA, the main sign of replication for many viruses (98) , and the subsequent activation of TBK1 (44). RIG-I contains a C-terminal RNA helicase domain as well as an N-terminal caspase recruitment domain (CARD) (44) . The interaction of the helicase domain with viral RNA or dsRNA may induce a conformational change of RIG-I and promote protein-protein interactions between the RIG-I CARD and other downstream CARD-containing proteins (Fig. 2, lower  panel) . Definitive evidence for the essential role of RIG-I for the IFN gene induction by RNA viruses has recently been obtained by generating MEFs deficient in Ddx58 (RIG-I gene) (99) . It has also been reported that the loss of the Fas-associated protein with the death domain (FADD) or the receptor-interacting protein 1 (RIP1) leads to a defect in IFN-b production against VSV infection (100). These reports point to the importance of RIP1 and FADD, which may be recruited to viral dsRNA recognizing RIG-I, in the regulation of the TBK1-mediated activation of IRF-7 and IRF-3 [the RIG-I-RIP1-FADD-TBK1-IRF-7(-3) pathway], although this possibility is yet to be rigorously assessed. The IFN induction pathway described above is operational in various cells, such as MEFs, and has been extensively studied in the context of innate antiviral immunity. Hence, it may be called 'the classical pathway' vis-à -vis the recently discovered TLR pathways of IFN induction (described below). Intriguingly, the RIP1-FADD-TBK1-IRF-7(3)-mediated IFN induction pathway is reminiscent of the Imd pathway in Drosophila (101, 102) . In Drosophila, Imd (a homologue of the mammalian RIP1) and Drosophila (d)FADD are required for the stimulation of the induction of anti-microbial gene expression through the activation of the NF-jB homologue Relish via an IKK complex (101, 102) . Therefore, this pathway may be highly conserved and may also be classical in the context of evolution. In turn, viruses have developed mechanisms for counteracting this classical pathway to evade from the host's immune responses (9) . For example, hepatitis C virus non-structural proteins 3 and 4A (NS3/4A) interfere with the functions of RIG-I and TBK1, thereby inhibiting the In addition, FADD and RIP1 have also been implicated in this activation pathway, but it remains to be clarified how these factors precisely contribute to the TBK1 activation. Activated TBK1 induces the phosphorylation of the specific serine residues of IRF-3 and IRF-7, resulting in the homodimerization of IRF-7 or the heterodimerization of IRF-7 and IRF-3. These dimmers then translocate to the nucleus and activate the IFN-a/b genes. IRF-7 and RIG-I are induced by IFN signaling, which is an essential aspect for the amplification of IFN-a/b signaling. Some viruses are known to block the activation of this pathway.
activation of IRF-3 during its infection (103) (104) (105) . Human respiratory syncytial virus NS1 and NS2 were also shown to suppress the activation and nuclear translocation of IRF-3 (106) . A better understanding of this pathway is therefore critical to establish an efficient therapeutic regulation of viral infections.
TLR signaling and induction of IFN genes

General overview
An exciting direction of IFN-a/b research was spawned by the discovery of TLRs. Indeed, the activation of many TLRs results in the induction of IFN-a and/or -b and this induction has received much attention in the context of linking innate and adaptive immunity (12) (13) (14) (15) (16) 20) . The TLR family consists of as many as 13 germline-encoded receptors in mammals that recognize various pathogen-associated molecules derived from bacteria, viruses, fungi and protozoa (15, 20, 101, 107) . All TLRs contain intracellular Toll/IL-1 receptor (TIR) domains, which transmit downstream signals via the recruitment of adaptor proteins such as myeloid differentiation primary response gene 88 (MyD88) (20, 101, (108) (109) (110) . MyD88 is linked to several effector molecules, such as IL-1R-associated kinases 1/4 (IRAK1/4), tumor necrosis factor receptorassociated factor 6 (TRAF6) and transforming growth factorb-activated kinase 1, and these molecules are linked to the activation of NF-jB, mitogen-activated protein kinases, extracellular signal-related kinases, p38 and c-Jun N-terminal kinase (JNK) (20, 101, (109) (110) (111) . Recent studies revealed that two IRF members, IRF-5 and IRF-7, are also activated by some of the TLRs via the MyD88 pathway (69, 112, 113) .
Although less studied than the above-mentioned MyD88 pathway, some TLRs also utilize additional adaptors, such as TIR-associated protein (TIRAP; also called MAL), TIR-domaincontaining adaptor-inducing IFN (TRIF; also called TICAM-1) and TRIF-related adaptor molecule (TRAM; also called TIRP or TICAM-2) (20, 108, (114) (115) (116) (117) (118) (119) . Thus, the versatility of the response may be mediated at least in part by the differential utilization of those adaptor proteins that activate overlapping but distinct downstream signaling pathways. TLR4 signaling is one of the best studied in this context, and it utilizes two signaling pathways, namely, the MyD88-TIRAP and TRAM-TRIF pathways (20, 108, (114) (115) (116) (117) (118) (119) . On the other hand, TLR9 subfamily members, TLR7, TLR8 and TLR9, transmit signals by solely utilizing MyD88 (20, (120) (121) (122) . Notwithstanding the utilization of distinct signaling pathways, the activation of TLR3, TLR4 and the TLR9 subfamily commonly triggers the IFN response (15-20, 108, 121, 122 ).
TLR4-mediated IFN induction
TLR4 is activated by LPS or the lipid A component of Gramnegative bacteria, as well as by some viral components such as the fusion protein of respiratory syncytial virus or the envelope proteins of mouse mammary tumor virus and Moloney murine leukemia virus (123) (124) (125) . Although it is not clear whether TLR4 is involved in the IFN response during viral infections, the TLR4 signal-mediated IFN-b gene induction (IFN-a is not induced in vitro) is best studied by LPS stimulation (17, 19, 20, (126) (127) (128) (129) .
It has been shown by gene-targeting studies that the LPSstimulated IFN-b induction via TLR4 is mostly if not entirely MyD88 independent (17), but TRAM-TRIF dependent (127) (128) (129) , whereas the induction of pro-inflammatory cytokine genes, such as tumor necrosis factor-a and IL-6, is dependent on both MyD88 and TRAM-TRIF (127-129). The genetargeting studies have revealed that the TBK1 but not IKKi is critical in this pathway (93, 94) . In TLR4 signaling, NAKassociated protein 1 (NAP1), which is recruited to TRIF, may be required to induce the oligomerization and activation of TBK1 (130) . It was shown that IRF-3, rather than IRF-7, is essential for this pathway (70, 84) . Irf3-deficient mice exhibited resistance to LPS-induced endotoxin shock (84) , and a central role of IFN-b in this shock was previously reported (131) . These reports indicate that IFN-b induction by TLR4 is mediated by the homodimer of IRF-3, which is activated by the TRAM-TRIF-NAP1-TBK1 pathway (Fig. 3) . Interestingly, however, if IRF-7 is up-regulated by the pretreatment with recombinant IFN-b, IFN-b mRNA induction by LPS can be observed even in Irf3 ÿ/ÿ DCs (84). Therefore, IRF-7 can be activated by TLR4 signaling, if expressed prior to the stimulation, and the LPS-activated IRF-7 has a potential to activate IFN-b gene induction.
TLR3-mediated IFN induction
TLR3 recognizes dsRNA, which is commonly produced during viral replication, and it is indeed required for the full induction of IFN-a/b and pro-inflammatory cytokines in response to exogenous stimulation with synthetic dsRNA or reovirus-derived dsRNA (18) . Similar to the case of TLR4, TLR3 activation can induce IFN-a/b expression via a MyD88-independent, TRIF-, NAP1-and TBK1-dependent signaling pathway (93, 94, 127, 128, 130) . Indeed, evidence has been provided that the activation of IRF-3 and the subsequent IFN-a/b induction are completely abolished in Trif-or Tbk1-deficient cells in response to stimulation by dsRNA (93, 94, 127, 128) , and Trif-deficient mice are highly susceptible to mouse cytomegalovirus infection (128) . However, unlike the TLR4-mediated IFN induction, the dsRNA-mediated induction of IFN-a/b mRNAs is still observed in Irf3-deficient DCs (84); this residual induction is completely abolished in DCs from Irf3 and Irf7 doubly deficient mice (K.H., unpublished result). Therefore, IRF-7 is also required for TLR3 signaling to fully induce the genes, although it is currently unknown which signaling pathway is linked to IRF-7 activation.
Difference between TLR3-and TLR4-mediated IFN inductions
From the above-mentioned observations, it can be interpreted that the mechanisms of TRIF-mediated IFN gene induction via TLR4 and via TLR3 are not the same. Indeed, TLR3 activation results in the induction of IFN-a as well as IFN-b, whereas TLR4 induces only IFN-b (17, 18, 132) . Although the precise mechanism underlying this interesting difference is currently unknown, it is possible that an additional signaling event might occur in the TLR3-TRIF pathway. In this context, it is noteworthy that TLR3 signaling up-regulates TLR3 expression via IFN signaling; type I IFNs induced by TLR3 signaling transcriptionally induces Tlr3 gene via ISGF3 activation, so as
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Unlike TLR4 that is expressed on the cell membrane, TLR3 is compartmentalized in intracellular organelles, such as endosomes (133) . It has been reported that endosomal acidification is necessary for TLR3 signaling (133) . Therefore, an additional molecule present in the endosomal compartment may also participate in the response in collaboration or in parallel with TLRs to induce IFN-a production. In this context, it is worth noting that tyrosine residues in the cytoplasmic domain of TLR3 need to be phosphorylated for the signaling (134). The phosphorylated tyrosine residues then recruit phosphatidylinositol-3 kinase (PI3K), and PI3K activity might be necessary for the endosomal trafficking of TLR3 as well as the activation of the Akt pathway to fully activate IRF-7 (135).
Additional evidence for the difference between TLR3 and TLR4 signalings was provided by the observation that the IRF-3-mediated activation of ISRE by TLR4, but not TLR3, requires the p65 subunit of NF-jB (RelA) (136) . TLR4 stimulation fails to activate ISRE in Rela-deficient MEFs, whereas the response to TLR3 in these cells is normal (136) . More recently, it has been shown that LPS-activated IRF-3 is recruited to the NF-jB site of IP10 (Cxcl10) and is necessary for the transcriptional activity of RelA (137) . These reports indicate that NF-jB and IRF-3 must cooperate in TLR4 signaling, but not TLR3 signaling, to a gene whose promoter contains an ISRE.
New IFN induction pathway activated by TLR9 subfamily
Recently, much attention has been focused on the high-level induction of IFN-a/b upon the activation of TLR9 subfamily members in plasmacytoid dendritic cells (pDCs), a small subset of DCs (122, (138) (139) (140) (141) (142) (143) . Accumulating evidence indicates that certain viruses induce the IFN-a/b gene via the activation of the TLR9 subfamily members TLR7, TLR8 and TLR9 (122, (144) (145) (146) (147) (148) (149) . For example, DNA viruses such as HSV contain a high number of unmethylated CpG motifs in their genomes, which are recognized by TLR9 and induce robust IFN production in pDCs (144, 145) . Likewise, TLR7/8 signaling is essential for IFN induction against influenza virus or VSV infection by recognizing viral genomic single-stranded RNA (ssRNA) (146) (147) (148) .
In contrast to TLR3-or TLR4-mediated TRIF-dependent IFN induction, the TLR9 subfamily members exclusively use MyD88 as their signaling adaptor for IFN induction (122, (144) (145) (146) (147) (148) (149) . Recently, evidence has been provided that MyD88 interacts with IRF-7 but not with IRF-3 in the cytoplasm (112, 113) . Fluorescence microscopy studies showed that a significant fraction of IRF-7 co-localizes with MyD88 in endosomal vesicles, whereas diffusely expressed IRF-3 does not colocalize with MyD88 (112, 113, 150) . Furthermore, fluorescence resonance energy transfer analysis revealed a direct interaction between IRF-7 and MyD88 (112, 113) . IRF-7 was also found to interact with TRAF6, another adaptor molecule functioning downstream of MyD88 (112, 113) . When cells expressing fluorescently tagged IRF-7 were stimulated with an IFN-inducing TLR9 ligand, A-or D-type unmethylated CpG DNA (CpG-A), the nuclear translocation of IRF-7 was observed (112) . Furthermore, upon co-transfection of expression plasmids for MyD88 and IRF-7 together with the IFN-b promoter-driven reporter gene, the reporter gene was strongly induced (112, 113) . Similar observations were made by coexpressing TRAF6 and IRF-7 (112, 113) . These in vitro studies suggest that IRF-7, but not IRF-3, interacts with and is activated by MyD88 and TRAF6 upon TLR9 stimulation to induce IFN gene induction (Fig. 4) .
Definitive evidence has been provided for the selective requirement of IRF-7 in IFN-a/b gene induction in pDCs via TLR9 subfamily activation in vivo (70) . Splenic pDCs derived from Irf7 ÿ/ÿ mice exhibit a profound defect in the induction of IFN-a/b stimulated either by viral infections (HSV and VSV) or by synthetic TLR ligands (CpG-A and ssRNA) (70) , whereas the induction is normal in pDCs from the mice deficient for previously implicated transcription factors, such as IRF-1, IRF-3, IRF-5 or Smad3 (36, 67, 151) . Therefore, a robust IFN Fig. 3 . TLR4-mediated IFN induction pathway. TLR4 signals through at least four adaptors: TIRAP, MyD88, TRAM and TRIF. These adaptors associate with many different signaling components and serve as platforms for the initiation of divergent signaling pathways. The oligomerization of MyD88 induces the recruitment and autophosphorylation of IRAK1 and IRAK4, which then associate with TRAF6, leading to the activation of NF-jB. On the other hand, TRAM and TRIF mediate the activation of IRF-3 as well as NF-jB. The C-terminal portion of TRIF associates with RIP1, which is responsible for TRIF-mediated NF-jB activation. The N-terminal portion of TRIF associates with TRAF6, which is also involved in NF-jB activation. In addition, the N-terminal portion of TRIF also associates with TBK1 through NAP1, which mediates the phosphorylation of IRF-3 (and IRF-7, if present). Phosphorylated IRF-3 forms homodimers, which associate with CBP/p300 in the nucleus (data not shown) and bind to the IFN-b promoter.
gene induction in pDCs is totally dependent on the activation of IRF-7. As mentioned above, IRF-7 is also essential for IFN induction mediated by TLR-MyD88-independent cytosolic detection of viruses in fibroblasts (classical IFN induction pathway) and appears to be the master regulator of the entire IFNdependent defense mechanism against viral infection (70) .
Activation of IRF-7 by TLR9 signaling
The mutation studies of MyD88 revealed that the death domain of MyD88 is responsible for MyD88 interaction with IRF-7 (112) . The death domain also interacts with the IRAK family of serine/threonine kinases, the signal transducer between MyD88 and TRAF6, suggesting the potential involvement of IRAKs in the IRF-7 pathway (20, 101, 109, 110, 152) . Indeed, pDCs derived from Irak4-deficient mice have a defect in IFN-a production, indicating the involvement of IRAK4 in IRF-7 phosphorylation (112). More recently, it has been shown that IRAK1 directly phosphorylates IRF-7 (153) . In vitro kinase assay revealed that IRAK1, but not IRAK4, phosphorylates recombinant IRF-7. Furthermore, Irak1 ÿ/ÿ pDCs exhibit a severe impairment of IFN-a induction but a normal induction of pro-inflammatory cytokines, when stimulated by ligands for TLR7 or TLR9 (153) . Considering the fact that IRAK4 is essential for both IFN-a and pro-inflammatory cytokine induction (153) , IRAK4 may act upstream of IRAK1 in the signaling and participate in the IRF-7 pathway via the phosphorylation of IRAK1. This IRF-7 activation pathway mediated by MyD88-IRAK4-IRAK1-TRAF6 appears to be powerful for IFN induction (Fig. 4) .
MyD88 signaling complex: the cytoplasmic transductional-transcriptional processor
In contrast to IFN-a/b gene induction, the activation of NF-jB, JNK and p38 occurs normally in Irf7-deficient DCs (70) . Furthermore, the induction of pro-inflammatory cytokines, such as IL-12 and IL-6, is not inhibited in Irf7-deficient DCs (70) . Therefore, the function of a cytoplasmic molecular complex anchored by MyD88 in the activation of NF-jB/MAP kinases is controlled independently of IRF-7, which selectively regulates the IFN limb of the MyD88-dependent cytokine gene induction program in TLR signaling. That is, the MyD88-dependent signaling may be modified by MyD88-interacting molecules that direct activation of their target genes in response to a given pathogen.
In addition to IRAKs and IRF-7, IRF-5 was also shown to interact with MyD88 to regulate the induction of pro-inflammatory cytokines (69) (Fig. 4) . Furthermore, the Toll-interacting protein (Tollip), Pellino1, Pellino2 and Pellino3 interact with IRAKs (154) (155) (156) (157) . Therefore, it is plausible that a highly ordered multimolecular complex organized around MyD88 exists in the cytoplasm and regulates the gene induction program. In analogy to the computing terminology, we named this multimolecular complex the cytoplasmic transductionaltranscriptional processor (CTTP) (112) . Depending on the nature of the input signal, CTTP may dynamically change its composition and determine the specificity, strength and longevity of the output, that is, transcriptional events. Further investigations are clearly required for determining the regulation of the proposed CTTP complex.
Systemic versus local IFN induction and action
Systemic IFN induction for innate antiviral immunity
A series of gene disruption studies revealed the contribution of the classical and TLR9 subfamily-MyD88-dependent IFN induction pathways, both mediated by IRF-7, to innate antiviral immunity. Irf7 ÿ/ÿ mice are highly vulnerable to infection by HSV or EMCV, and IFN-a induction is markedly inhibited in the sera of Irf7 ÿ/ÿ mice infected with either of these viruses (70) . On the other hand, Irf3 ÿ/ÿ mice and Myd88 ÿ/ÿ mice are more resistant to these viral infections, and the IFN-a induction level is almost the same as that of the wild-type mice (70) . In view of the fact that IFN induction is entirely dependent on the TLR9-MyD88 pathway in HSV-infected splenic pDCs (144, 145) , these results suggest that the classical IFN-a/b induction pathway, which is less effective than the MyD88-IRF-7-dependent induction pathway in pDCs but operational in many cell types, constitutes a critical part of the innate antiviral defense, wherein IRF-7 also plays an essential role. On the other hand, it is possible that, depending on the virus type or viral load, the TLR-MyD88-dependent pathways may also participate in the antiviral response.
Local IFN induction for antigen-specific T cell response
The importance of the MyD88-dependent IFN induction pathway was underscored by the finding of the in vivo induction of antigen-specific CD8 + T cell response. When Myd88 ÿ/ÿ or Irf7 ÿ/ÿ mice were immunized with soluble ovalbumin (OVA) and CpG-A, the induction of antigen-specific CD8 + T cells was severely impaired (70) . This CpG-Adependent, OVA-specific CD8 + T cell response is dependent on pDCs, because the pre-treatment of wild-type mice with 120G8, the antibody that allows a selective depletion of pDCs (158) , inhibits the response (70) . These results collectively demonstrate the selective and essential role of the MyD88-IRF-7 pathway in pDCs in the TLR9-mediated triggering of the CD8 + T cell response, which is mediated by IFN production. In this context, it is interesting to note that pDCs are found predominantly in the T cell areas of secondary lymphoid organs (139, 143) , implying that IFN-a/b produced by pDCs may act 'locally' to induce DC maturation, which effectively couples with the induction of CD8 + T cell-mediated adaptive immunity. It is worth noting that the requirement of the MyD88-IRF-7-IFN pathway is not applicable for other TLRs, which are also involved in the induction of T cell response via the MyD88-dependent signaling pathway: When the adjuvant used was a mycoplasmal lipopeptide, which activates TLR2 (and TLR6) (159), the deficiency in T cell response was observed in Myd88 ÿ/ÿ mice but not in Irf7 ÿ/ÿ mice (70), indicating the operation of the MyD88-dependent, IRF-7-independent gene activation program for this TLR-induced T cell response.
Future prospects
There is accumulating evidence for multiple signaling pathways for IFN induction. The immune system makes proper use of the IRF-IFN system to induce diverse responses. In addition to the classically known signaling pathways, the list of newly identified IFN induction signaling pathways is rapidly growing
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at Pennsylvania State University on February 22, 2013 http://intimm.oxfordjournals.org/ and will continue to grow. The classical pathways will also continuously need to be re-evaluated.
In contrast to the beneficial aspects of the IFN system on the host defense against viral infection or oncogenesis, accumulating evidence also suggests that an aberrant activation of immune systems by high levels of IFN-a/b contributes to the development of autoimmune diseases, such as systemic lupus erythematosus (SLE) (160) (161) (162) . An aberrant activation of the MyD88-IRF-7 pathway might be responsible for pathogenesis of this disease. In this context, it is interesting that the TLR9-MyD88-IRF-7 signaling pathway is under spatiotemporal regulation, wherein a prolonged signaling in endosomes is critical for a robust IFN induction (150) , and that in patients with SLE, a complex of anti-DNA antibodies and DNA is present and it binds to and enters into the endosomes of pDCs via FcR-mediated endocytosis (163) .
Further understanding of the IRF-IFN system should provide important insights into improvements in therapeutic interventions for numerous diseases related to infection and immunity.
Abbreviations AAF IFN-a-activated factor APC antigen-presenting cells 
